THE IDENTIFICATION AND SYSTEMATIZATION OF FINANCIAL ASSETS AND LIABILITIES, EXPOSED TO FINANCIAL RISKS, ON THE EXAMPLE OF THE PHARMACEUTICAL INDUSTRY

The best methods of identification of the financial assets and liabilities with highest risk concentration on the example of pharmaceutical companies have been considered. It is well known, that significant risks are subject to disclosure in financial statements of organization, because they can inf...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: O. Ageeva, A. Yolkina
Formato: article
Lenguaje:RU
Publicado: Publishing House of the State University of Management 2019
Materias:
Acceso en línea:https://doaj.org/article/e785eea84cd64a1ab7ddf7449881eeb0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e785eea84cd64a1ab7ddf7449881eeb0
record_format dspace
spelling oai:doaj.org-article:e785eea84cd64a1ab7ddf7449881eeb02021-12-03T07:43:29ZTHE IDENTIFICATION AND SYSTEMATIZATION OF FINANCIAL ASSETS AND LIABILITIES, EXPOSED TO FINANCIAL RISKS, ON THE EXAMPLE OF THE PHARMACEUTICAL INDUSTRY1816-42772686-841510.26425/1816-4277-2019-6-134-142https://doaj.org/article/e785eea84cd64a1ab7ddf7449881eeb02019-06-01T00:00:00Zhttps://vestnik.guu.ru/jour/article/view/1520https://doaj.org/toc/1816-4277https://doaj.org/toc/2686-8415The best methods of identification of the financial assets and liabilities with highest risk concentration on the example of pharmaceutical companies have been considered. It is well known, that significant risks are subject to disclosure in financial statements of organization, because they can influence management decisions. It is important for professionals to understand how to correctly identify and assess the risks, influencing the financial statements, as well as to form a list of assets and liabilities, that are more affected by them. The above questions can be answered by the approaches presented in the article to the identification, assessment and systematization of risks, their impact on the financial statements, as well as the conclusions, formulated by the authors as a result of the research.O. AgeevaA. YolkinaPublishing House of the State University of Managementarticlerisk identificationfinancial statementsrisk mapinternal control and audit systemreflection of informationpharmaceutical industrySociology (General)HM401-1281Economics as a scienceHB71-74RUВестник университета, Vol 0, Iss 6, Pp 134-142 (2019)
institution DOAJ
collection DOAJ
language RU
topic risk identification
financial statements
risk map
internal control and audit system
reflection of information
pharmaceutical industry
Sociology (General)
HM401-1281
Economics as a science
HB71-74
spellingShingle risk identification
financial statements
risk map
internal control and audit system
reflection of information
pharmaceutical industry
Sociology (General)
HM401-1281
Economics as a science
HB71-74
O. Ageeva
A. Yolkina
THE IDENTIFICATION AND SYSTEMATIZATION OF FINANCIAL ASSETS AND LIABILITIES, EXPOSED TO FINANCIAL RISKS, ON THE EXAMPLE OF THE PHARMACEUTICAL INDUSTRY
description The best methods of identification of the financial assets and liabilities with highest risk concentration on the example of pharmaceutical companies have been considered. It is well known, that significant risks are subject to disclosure in financial statements of organization, because they can influence management decisions. It is important for professionals to understand how to correctly identify and assess the risks, influencing the financial statements, as well as to form a list of assets and liabilities, that are more affected by them. The above questions can be answered by the approaches presented in the article to the identification, assessment and systematization of risks, their impact on the financial statements, as well as the conclusions, formulated by the authors as a result of the research.
format article
author O. Ageeva
A. Yolkina
author_facet O. Ageeva
A. Yolkina
author_sort O. Ageeva
title THE IDENTIFICATION AND SYSTEMATIZATION OF FINANCIAL ASSETS AND LIABILITIES, EXPOSED TO FINANCIAL RISKS, ON THE EXAMPLE OF THE PHARMACEUTICAL INDUSTRY
title_short THE IDENTIFICATION AND SYSTEMATIZATION OF FINANCIAL ASSETS AND LIABILITIES, EXPOSED TO FINANCIAL RISKS, ON THE EXAMPLE OF THE PHARMACEUTICAL INDUSTRY
title_full THE IDENTIFICATION AND SYSTEMATIZATION OF FINANCIAL ASSETS AND LIABILITIES, EXPOSED TO FINANCIAL RISKS, ON THE EXAMPLE OF THE PHARMACEUTICAL INDUSTRY
title_fullStr THE IDENTIFICATION AND SYSTEMATIZATION OF FINANCIAL ASSETS AND LIABILITIES, EXPOSED TO FINANCIAL RISKS, ON THE EXAMPLE OF THE PHARMACEUTICAL INDUSTRY
title_full_unstemmed THE IDENTIFICATION AND SYSTEMATIZATION OF FINANCIAL ASSETS AND LIABILITIES, EXPOSED TO FINANCIAL RISKS, ON THE EXAMPLE OF THE PHARMACEUTICAL INDUSTRY
title_sort identification and systematization of financial assets and liabilities, exposed to financial risks, on the example of the pharmaceutical industry
publisher Publishing House of the State University of Management
publishDate 2019
url https://doaj.org/article/e785eea84cd64a1ab7ddf7449881eeb0
work_keys_str_mv AT oageeva theidentificationandsystematizationoffinancialassetsandliabilitiesexposedtofinancialrisksontheexampleofthepharmaceuticalindustry
AT ayolkina theidentificationandsystematizationoffinancialassetsandliabilitiesexposedtofinancialrisksontheexampleofthepharmaceuticalindustry
AT oageeva identificationandsystematizationoffinancialassetsandliabilitiesexposedtofinancialrisksontheexampleofthepharmaceuticalindustry
AT ayolkina identificationandsystematizationoffinancialassetsandliabilitiesexposedtofinancialrisksontheexampleofthepharmaceuticalindustry
_version_ 1718373544911437824